The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 09, 2022
Filed:
Dec. 21, 2018
Applicants:
Taiwan Liposome Co., Ltd, Taipei, TW;
Tlc Biopharmaceuticals, Inc., South San Francisco, CA (US);
Inventors:
Assignees:
Taiwan Liposome Co., Ltd, Taipei, TW;
TLC Biopharmaceuticals, Inc., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/454 (2006.01); A61K 9/127 (2006.01); A61K 31/4025 (2006.01); A61K 31/404 (2006.01); A61K 31/4196 (2006.01); A61K 31/422 (2006.01); A61K 47/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/454 (2013.01); A61K 9/127 (2013.01); A61K 31/404 (2013.01); A61K 31/4025 (2013.01); A61K 31/4196 (2013.01); A61K 31/422 (2013.01); A61K 47/28 (2013.01);
Abstract
Provided is a sustained-release triptan composition as a suitable depot formulation to carry a therapeutically effective amount of triptan for administration via subcutaneous or intramuscular injection. This sustained-release triptan composition is characterized by a high drug to phospholipid ratio and provides an improved pharmacokinetic profile in vivo. The sustained-release triptan composition is for use as a medicament in the treatment of migraine or cluster headache.